Artwork

Innehåll tillhandahållet av Darshan Kulkarni. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Darshan Kulkarni eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

AI Data Ownership in Pharma

4:59
 
Dela
 

Manage episode 443385753 series 3506216
Innehåll tillhandahållet av Darshan Kulkarni. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Darshan Kulkarni eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

We explore how AI is transforming content generation in the pharmaceutical industry, particularly in marketing, sales, and medical engagements. While AI presents groundbreaking opportunities, it also raises critical challenges, notably concerning data ownership and compliance.
A significant issue is the lack of clarity around ownership of input and output data, illustrated by legal disputes like The New York Times suing OpenAI. For pharma companies, the stakes are high due to stringent FDA regulations. Missteps in AI-generated promotional materials can lead to hefty fines and reputational damage.
We discuss the importance of rigorous internal reviews (PRC and MLR) for sales and marketing teams to ensure compliance and accuracy. Medical Affairs must also prioritize precision in AI-generated content to avoid misinformation that could harm patients.
AI holds immense potential, but navigating issues of data ownership, regulatory compliance, and accuracy is essential for pharma companies. Join us for more discussions on AI in pharma, and feel free to reach out with topics you'd like us to cover!

Support the show

  continue reading

138 episoder

Artwork
iconDela
 
Manage episode 443385753 series 3506216
Innehåll tillhandahållet av Darshan Kulkarni. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Darshan Kulkarni eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

We explore how AI is transforming content generation in the pharmaceutical industry, particularly in marketing, sales, and medical engagements. While AI presents groundbreaking opportunities, it also raises critical challenges, notably concerning data ownership and compliance.
A significant issue is the lack of clarity around ownership of input and output data, illustrated by legal disputes like The New York Times suing OpenAI. For pharma companies, the stakes are high due to stringent FDA regulations. Missteps in AI-generated promotional materials can lead to hefty fines and reputational damage.
We discuss the importance of rigorous internal reviews (PRC and MLR) for sales and marketing teams to ensure compliance and accuracy. Medical Affairs must also prioritize precision in AI-generated content to avoid misinformation that could harm patients.
AI holds immense potential, but navigating issues of data ownership, regulatory compliance, and accuracy is essential for pharma companies. Join us for more discussions on AI in pharma, and feel free to reach out with topics you'd like us to cover!

Support the show

  continue reading

138 episoder

Alla avsnitt

×
 
Loading …

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

 

Snabbguide